MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

SYK · NYSE

Stryker Corporation

Health Care · Medical/Dental Instruments

Reference price$346.60As of Jul 28, 2026
Market capitalization$133B
52-week range$281.00–$404.14
S&P 500 portfolio weight0.18%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$315.00-9.1% vs. reference
Average$385.50+11.2% vs. reference
High$455.00+31.3% vs. reference
19 Buy4 Hold0 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportJul 30, 2026Jun 2026
Consensus EPS$3.467 estimates
Expected range$3.36–$3.61Low to high EPS
Dec 2026$14.99Street EPS consensus
Dec 2027$16.59Street EPS consensus
Dec 2028$18.19Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Dec 31, 2025.

MetricCurrentPrior
Revenue+11.2% YoY$25.12B$22.6B
Operating income$4.89B$3.69B
Net income$3.25B$2.99B
Operating cash flow$5.04B$4.24B
Capital expenditures($0.76B)($0.76B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

J&J's MedTech Performance Slows in Q2: Will Sales Improve in H2?

Zacks

PAHC vs. SYK: Which Stock Is the Better Value Option?

Zacks

Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.